Clinical Trial Results
Showing:
All studies
[change]
Condition: COPD
25 trials found
New Search
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
RECRUITING
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING
COPD Exacerbation Follow Up
RECRUITING
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
RECRUITING
Early Detection of COPD Exacerbations Using Home Monitoring Device
RECRUITING
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
RECRUITING
Functional Social Support in COPD Self-Management
RECRUITING
SPIROMICS Study of Early COPD Progression (SOURCE)
RECRUITING
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
RECRUITING
PiMZ Longitudinal Cohort (PiMZ Logic)
RECRUITING
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
RECRUITING
Effectiveness of the WearME System for COPD Severity and Respiratory Function
RECRUITING
Temple Health Chest Initiative (THCI 2.0)
RECRUITING
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RECRUITING
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RECRUITING
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RECRUITING
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RECRUITING
Trial to Determine Effective Aspirin Dose in COPD
RECRUITING
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
RECRUITING
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
RECRUITING
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
RECRUITING